UBX
Unity Biotechnology
Delisted
UBX was delisted on the 8th of July, 2025.
84 hedge funds and large institutions have $216M invested in Unity Biotechnology in 2020 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 31 increasing their positions, 14 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
14% more funds holding
Funds holding: 74 → 84 (+10)
0.47% more ownership
Funds ownership: 4.6% → 5.07% (+0.47%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
84
Holding in Top 10
2
Calls
$256K
Puts
$1K
Top Buyers
| 1 | +$5.94M | |
| 2 | +$4.35M | |
| 3 | +$3.02M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.73M |
| 5 |
MAM
Martingale Asset Management
Boston,
Massachusetts
|
+$1.65M |
Top Sellers
| 1 | -$562K | |
| 2 | -$484K | |
| 3 | -$348K | |
| 4 |
MSAM
Moloney Securities Asset Management
Manchester,
Missouri
|
-$264K |
| 5 |
VEA
Virtus ETF Advisers
New York
|
-$249K |